1. Pre-clinical characterization of avelumab (anti-human PD-L1) reveals an enhanced anti-tumor efficacy in hIgG1 isotype. (December 2016) Authors: Qu, Y.; Prior, W.W.; Abdiche, Y.; Chen, W.; Potluri, S.; Chaparro-Riggers, J.; Patel, P.; Lin, J. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗